1.Characteristics of CT Perfusion Parameters of Focal Pancreatic Lesions and Data Comparison of Different Algorithms.
Ping LI ; Liang ZHU ; Huadan XUE ; Changyi LIU ; Kai XU ; Juan LI ; Ting SUN ; Zhengyu JIN
Acta Academiae Medicinae Sinicae 2017;39(1):80-87
Objective To characterize the CT perfusion parameters of focal pancreatic lesions including pancreatic cancers (PACs) and pancreatic neuroendocrine tumors (pNETs),estimate the confirmity and fungibility of parameters obtained from Deconvolution and Maximum slope+Patlak.Methods From December 2015 to November 2016,22 patients with PACs and 22 patients with pNETs(37 lesions confirmed by surgery and biopsy)underwent preoperative whole-pancreas CT perfusion in our center. The volume perfusion CT of the entire pancreas was performed at 80 kV and 100 mA,using 28 consecutive volume measurements and intravenous injection of 45 ml of iodinated contrast and saline at a flow rate of 5 ml/s. One experienced radiologists measured and recorded the CT perfusion parameters on Siemens post-processing workstation using two mathematical methods:Maximum slope+Patlak analysis versus Deconvolution method.ResultsWilcoxon matched-pairs test revealed significant difference between both pairs of the perfusion measurements by the two methods,PACs(BFM vs. BFD,Z=-3.263,P=0.001;BVD vs. BVP,Z=-3.978,P=0.000); pNETs(BFM vs. BFD,Z=-5.212,P=0.000;BVD vs. BVP,Z=-2.633,P=0.008). Spearman's correlation coefficient showed both pairs of perfusion measurements significantly correlated with each other in PACs (BFM vs. BFD,r=0.845,P=0.000;BVD vs. BVP,r=0.964,P=0.000) and pNETs(BFM vs. BFD,r=0.759,P=0.000),BVD vs. BVP,r=0.683,P=0.000). Geometric mean BFM/BFD ratio in PACs was 0.77 (range:0.61-0.99),while geometric mean BVD/BVP ratio was 1.42 (range:1.13-1.79),within 95% limits of agreement. Geometric mean BFM/BFD ratio in pNETs was 0.66 (range:0.51-0.86),while geometric mean BVD/BVP ratio was 1.15 (range:0.88-1.50),within 95% limits of agreement. Conclusion sSignificantly different CT perfusion values of blood flow and blood volume were obtained by Deconvolution-based and Maximum slope+Patlak-based algorithms in the pNETs and PACs. They correlated significantly with each other. Two perfusion-measuring algorithms are interchangeable because the ranges of the conversion factors are narrow.
Algorithms
;
Blood Volume
;
Contrast Media
;
Humans
;
Pancreas
;
diagnostic imaging
;
pathology
;
Pancreatic Neoplasms
;
diagnostic imaging
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed
;
methods
2.Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma.
Eun Byul KWON ; Hwal Rim JEONG ; Young Seok SHIM ; Hae Sang LEE ; Jin Soon HWANG
Journal of Korean Medical Science 2016;31(6):1003-1006
Multiple endocrine neoplasia (MEN) mutation is an autosomal dominant disorder characterized by the occurrence of parathyroid, pancreatic islet, and anterior pituitary tumors. The incidence of insulinoma in MEN is relatively uncommon, and there have been a few cases of MEN manifested with insulinoma as the first symptom in children. We experienced a 9-year-old girl having a familial MEN1 mutation. She complained of dizziness, occasional palpitation, weakness, hunger, sweating, and generalized tonic-clonic seizure that lasted for 5 minutes early in the morning. At first, she was only diagnosed with insulinoma by abdominal magnetic resonance images of a 1.3 × 1.5 cm mass in the pancreas and high insulin levels in blood of the hepatic vein, but after her father was diagnosed with MEN1. We found she had familial MEN1 mutation, and she recovered hyperinsulinemic hypoglycemia after enucleation of the mass. Therefore, the early genetic identification of MEN1 mutation is considerable for children with at least one manifestation.
Alleles
;
Base Sequence
;
Child
;
DNA Mutational Analysis
;
Female
;
Humans
;
Hypoglycemia/diagnosis
;
Insulin/blood
;
Insulinoma/diagnostic imaging/*pathology
;
Magnetic Resonance Imaging
;
Multiple Endocrine Neoplasia Type 1/*diagnosis/pathology
;
Pancreatic Neoplasms/diagnostic imaging/*pathology
;
Pedigree
;
Polymorphism, Single Nucleotide
;
Proto-Oncogene Proteins/genetics
;
Seizures/complications
3.Liquid-based cytology diagnosis of endoscopic ultrasound-guided fine needle aspiration of pancreatic lesions.
Li GAO ; Minghua ZHANG ; Xiangjie HE ; Xiaohua MAN ; Yan ZHU ; Jianming ZHENG
Chinese Journal of Pathology 2016;45(1):43-46
OBJECTIVETo investigate the diagnostic value of liquid-based cytology test (LCT) in pancreatic lesions sampled by ultrasound-guided fine needle aspiration (EUS-FNA).
METHODSA retrospective analysis of 556 cases of LCT smears sampled by EUS-FNA of pancreatic lesions was performed, and 164 cases had histologic diagnosis with subsequent surgical resection or biopsy and immunohistochemistry. The accuracy of the cytologic diagnosis was assessed using the histologic diagnosis as the gold standard. The discrepant cases were reviewed to identify sources of errors.
RESULTSThe satisfactory rate for EUS-FNA was 96.0%(534/556). The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were 87.7%(128/146), 13/16, 97.7%(128/131), 41.9%(13/31) and 87.0%(141/162) respectively. The diagnostic accuracy was lower in cystic lesions than that in solid lesions. The LCT sensitivities of adenocarcinoma, lymphoma and neuroendocrine tumors were higher than those of cystic tumors and mesenchymal tumors. False positive diagnosis was mainly due to epithelial abnormalities in inflammatory reaction. False negative diagnosis was mainly due to scanty or lack of tumor cells in the smears, or mild atypia that was insufficient for diagnosis.
CONCLUSIONSEUS-FNA is a valuable tool for the diagnosis of pancreatic lesions. Standardized terminology and nomenclature are helpful to improve the diagnostic accuracy.
Adenocarcinoma ; diagnosis ; Endoscopic Ultrasound-Guided Fine Needle Aspiration ; Humans ; Inflammation ; Neoplasms, Connective and Soft Tissue ; diagnosis ; Neuroendocrine Tumors ; diagnosis ; Pancreas ; cytology ; diagnostic imaging ; pathology ; Pancreatic Neoplasms ; diagnosis ; Retrospective Studies ; Sensitivity and Specificity ; Specimen Handling
4.The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.
Cindy CHEW ; Patrick J O'DWYER
Singapore medical journal 2016;57(6):334-338
INTRODUCTIONAccurate staging of patients with pancreatic cancer is important to avoid unnecessary operations. The aim of this study was to prospectively assess the impact of magnetic resonance (MR) imaging on preoperative staging of liver in patients with findings of resectable pancreatic cancer on computed tomography (CT).
METHODSAll patients who presented to a tertiary referral centre with pancreatic cancer between April 2012 and December 2013 were included in the study. Patients with findings of resectable disease on CT underwent further liver diffusion-weighted MR imaging, using a hepatocyte-specific contrast agent.
RESULTSA total of 583 patients with pancreatic cancer were referred. 69 (11.8%) had resectable disease on CT. Of these 69 patients, 16 (23.2%) had liver metastases on MR imaging, while 6 (8.7%) had indeterminate lesions. Of the 16 patients with positive MR imaging findings of liver metastases, 11 died of pancreatic cancer, with a mean survival time of nine months (95% confidence interval [CI] 5.22-14.05). The mean survival time of the 47 patients with negative MR imaging findings was 16 months (95% CI 14.33-18.10; p = 0.001). Subsequently, 22 of these patients underwent surgery, and only 1 (4.5%) patient was found to have liver metastasis at surgery.
CONCLUSIONThe results of the present study indicate that MR imaging improves the staging of disease in patients with resectable pancreatic cancer.
Adult ; Aged ; Female ; Humans ; Liver ; diagnostic imaging ; pathology ; Liver Neoplasms ; diagnostic imaging ; pathology ; secondary ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Pancreatic Neoplasms ; diagnostic imaging ; pathology ; Prospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome ; Unnecessary Procedures
5.CT imaging features and their correlation with pathological findings of solid pseudopapillary tumor of pancreas.
Xingju ZHENG ; Xianzheng TAN ; Bing WU
Journal of Biomedical Engineering 2014;31(1):107-112
To analyze the CT features of solid pseudopapillary tumor of pancreas (SPTP), and correlation with the pathological findings of the disease so as to improve the diagnostic abilities, the CT images and the clinical manifestations, we retrospectively analyzed the pathological materials of 23 cases with surgery and pathology proved SPTP. In the 23 patients, 21 cases were female (91.3%) and 2 were male (8.7%). The most common symptom was abdominal discomfort with dull pain in 12 patients (52.2%). Others included the pancreatic mass that was detected incidentally during physical examination in 9 patients (39.1%), nausea/vomiting in 2 patients (8.7%). And 1 case of female patients had 2 lesions. In the 24 tumors, 6 cases were located at the head (25.0%), 3 were at neck (12.5%), 8 cases were at body (33.3%), and 7 cases were at tail of pancreas respectively (29.2%). The long-axis diameter ranged from 2.1 cm to 20.1 cm (mean 6.4 cm). 9 tumors were mostly solid component (37.5%), 10 tumors were contained similar proportion of solid and cystic part (41.7%), and mainly cystic components in 5 tumors (20.8%). In 9 of the 23 patients, calcification was found in the tumor (39.1%). In 2 of the 23 patients, bleeding was seen in the mass (8.7%). The dilation of intrahepatic bile duct was found in 1 patient (8.7%). Liver metastasis was showed in one patient (8.7%). On post-contrast CT scan, solid parts demonstrated mild enhancement at the arterial phase. At the portal phase, solid parts were enhanced continuously in all cases, and the enhancement degrees were lower than normal pancreatic tissue. The cystic parts of all lesions showed no enhancement. Pseudo papillary structure, hemorrhage, necrosis, or cystic degeneration were found in all patients by histological study. In a word, SPTP has comparatively characteristic CT imaging features consistent with histological features, when combined with clinical manifestations, could be correctly diagnosed and differentially diagnosed.
Bile Ducts, Intrahepatic
;
Calcinosis
;
diagnostic imaging
;
Female
;
Humans
;
Liver Neoplasms
;
secondary
;
Male
;
Pancreas
;
diagnostic imaging
;
pathology
;
Pancreatic Neoplasms
;
diagnostic imaging
;
pathology
;
Retrospective Studies
;
Tomography, X-Ray Computed
6.Pancreatic pseudocyst or a cystic tumor of the pancreas?
Mohammad Ezzedien RABIE ; Ismail El HAKEEM ; Mohammad Saad Al SKAINI ; Ahmad El HADAD ; Salim JAMIL ; Mian Tahir SHAH ; Mahmoud OBAID
Chinese Journal of Cancer 2014;33(2):87-95
Pancreatic pseudocysts are the most common cystic lesions of the pancreas and may complicate acute pancreatitis, chronic pancreatitis, or pancreatic trauma. While the majority of acute pseudocysts resolve spontaneously, few may require drainage. On the other hand, pancreatic cystic tumors, which usually require extirpation, may disguise as pseudocysts. Hence, the distinction between the two entities is crucial for a successful outcome. We conducted this study to highlight the fundamental differences between pancreatic pseudocysts and cystic tumors so that relevant management plans can be devised. We reviewed the data of patients with pancreatic cystic lesions that underwent intervention between June 2007 and December 2010 in our hospital. We identified 9 patients (5 males and 4 females) with a median age of 40 years (range, 30-70 years). Five patients had pseudocysts, 2 had cystic tumors, and 2 had diseases of undetermined pathology. Pancreatic pseudocysts were treated by pseudocystogastrostomy in 2 cases and percutaneous drainage in 3 cases. One case recurred after percutaneous drainage and required pseudocystogastrostomy. The true pancreatic cysts were serous cystadenoma, which was treated by distal pancreatectomy, and mucinous cystadenocarcinoma, which was initially treated by drainage, like a pseudocyst, and then by distal pancreatectomy when its true nature was revealed. We conclude that every effort should be exerted to distinguish between pancreatic pseudocysts and cystic tumors of the pancreas to avoid the serious misjudgement of draining rather than extirpating a pancreatic cystic tumor. Additionally, percutaneous drainage of a pancreatic pseudocyst is a useful adjunct that may substitute for surgical drainage.
Adult
;
Aged
;
Cystadenocarcinoma, Mucinous
;
diagnostic imaging
;
pathology
;
surgery
;
Cystadenoma, Serous
;
diagnostic imaging
;
pathology
;
surgery
;
Diagnostic Errors
;
Drainage
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pancreatectomy
;
Pancreatic Cyst
;
diagnostic imaging
;
pathology
;
surgery
;
Pancreatic Neoplasms
;
diagnostic imaging
;
pathology
;
surgery
;
Pancreatic Pseudocyst
;
diagnostic imaging
;
pathology
;
surgery
;
Retrospective Studies
;
Tomography, X-Ray Computed
7.Clinics in diagnostic imaging (157). Acinar cell carcinoma (ACC) of the pancreatic tail.
Marcus Jian Fu ONG ; Yee Lin TANG ; Cher Heng TAN
Singapore medical journal 2014;55(11):564-quiz 568
A 50-year-old Chinese man presented to the clinic with left hypochondrial pain, more than 10 kg of weight loss over a 3-month period, and a firm, large, ill-defined mass in the left upper quadrant. Contrast-enhanced computed tomography of the abdomen and pelvis revealed a well-circumscribed exophytic pancreatic mass with features suggestive of acinar cell carcinoma (ACC). The patient underwent chemotherapy and radiotherapy, with no evidence of local recurrence detected at one-year follow-up. He remains under close surveillance by his oncologist. Treatment for ACC includes surgical resection with adjuvant radiotherapy. Better overall survival is seen in patients with surgically resectable ACC as compared to those with the more common ductal cell carcinoma.
Carcinoma, Acinar Cell
;
diagnostic imaging
;
pathology
;
Humans
;
Male
;
Middle Aged
;
Pancreatic Neoplasms
;
diagnostic imaging
;
pathology
;
Tomography, X-Ray Computed
8.Feasibility and safety of CT-guided percutaneous needle biopsy and subsequent iodine-125 seed interstitial implantation for pancreatic cancer.
Yan-ping YU ; Hai-tao JIANG ; Zheng YAO ; Qi-rong XIA ; Feng-ming HONG ; Hui ZENG ; Sheng LI
Chinese Journal of Oncology 2013;35(8):608-612
OBJECTIVETo discuss the feasibility and safety of different approaches for CT-guided percutaneous needle biopsy and subsequent iodine-125 seed interstitial implantation for pancreatic cancer.
METHODSA retrospective study was carried out on the complete data of 35 patients with pancreatic cancer who have received CT-guided percutaneous needle biopsy with or without subsequent iodine-125 seed interstitial implantation. There were 9 lesions located in the head of pancreas, 20 located in the body, and 6 in the tail. The maximum diameter of the lesions varied from 12 mm to 60 mm (mean 37.1 mm). The patients were treated with a needle in diameter of 16-21G. Operations were undertaken via anterior, posterior and lateral approaches.
RESULTSThirty-five patients underwent 43 times of CT-guided percutaneous needle biopsies. Thirty-one cases were pathologically diagnosed as cancer, 2 cases inflammatory lesions, and 2 were suspected tumors (one of which was finally diagnosed as cancer, while another was pancreatic pseudocyst). The ratio of correct diagnosis was 94.3%. Fourteen patients were treated subsequently with CT-guided iodine-125 seed interstitial implantation therapy, with a total of 65 times of needle puncture. The operations were performed via direct approach to the tumor in 18 cases, transhepatic approach in 2 cases, transgastric approach in 4 cases, transintestinal approach in 10 cases, and through mesenteric vessels in one case. Incidence of complications in the biopsy group was 2.32% (1/43), and in the implantation group was 6.15% (4/65), with a statistically non-significant difference (P = 0.600) between the two groups. Incidence of complications in the group using 16-18G needle was 4.65% (4/86), while in the group using 20-21G needle was 4.55% (1/22), also with a non-significant difference (P = 0.064). The accuracy rate of needle biopsy in this study was 94.28% (33/35).
CONCLUSIONCT-guided percutaneous needle biopsy and subsequent iodine-125 seed interstitial implantation are both feasible and safe for pancreatic cancer.
Adult ; Aged ; Aged, 80 and over ; Biopsy, Needle ; methods ; Brachytherapy ; methods ; Female ; Follow-Up Studies ; Humans ; Iodine Radioisotopes ; therapeutic use ; Male ; Middle Aged ; Pancreatic Neoplasms ; diagnostic imaging ; pathology ; radiotherapy ; Radiography, Interventional ; methods ; Retrospective Studies ; Tomography, X-Ray Computed
9.A Case of Intrapancreatic Accessory Spleen Mistaken as a Pancreatic Mass due to Different Enhancing Pattern from Normal Spleen.
Jun Seok PARK ; Wan Jung KIM ; Yeong Gyu JEONG ; Youn Sun PARK ; Hyun Cheol KOO ; Tae Il LEE ; Gyo Chang CHOI ; Sook KIM
The Korean Journal of Gastroenterology 2011;58(6):357-360
Most cases of accessory spleen show similar features as normal spleen in imaging studies. However, some accessory spleen has unusual scan feature which can be misdiagnosed. We present a case of intrapancreatic accessory spleen that was discovered incidentally during a workup for abdominal pain in a 47-year-old woman. CT and MRI revealed a different enhancing pattern from that of the spleen. Further evaluation with endoscopic ultrasonography failed to identify the pancreatic mass. Therefore, it was surgically removed and diagnosed pathologically as an accessory spleen.
Diagnostic Errors
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Middle Aged
;
Pancreatectomy
;
Pancreatic Neoplasms/radionuclide imaging/surgery/ultrasonography
;
Spleen/*pathology/radionuclide imaging/surgery
;
Tomography, X-Ray Computed
10.A Case of Pancreatic Neuroendocrine Tumor with Multiple Hepatic Metastasis.
Chang Hwan PARK ; Sung Kyu CHOI
The Korean Journal of Gastroenterology 2010;55(5):275-278
No abstract available.
Aged
;
Fluorodeoxyglucose F18/diagnostic use
;
Humans
;
Liver Neoplasms/*diagnosis/pathology/secondary
;
Magnetic Resonance Imaging
;
Male
;
Neuroendocrine Tumors/*diagnosis/radionuclide imaging/secondary
;
Pancreatic Neoplasms/*diagnosis/pathology/radionuclide imaging
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed

Result Analysis
Print
Save
E-mail